Ultrasensitive Interferons quantification in idiopathic inflammatory myopathies serve as biomarkers of activity in dermatomyositis and anti-synthetase syndrome

MLA

llibre A, et al. Ultrasensitive Interferons Quantification in Idiopathic Inflammatory Myopathies Serve as Biomarkers of Activity in Dermatomyositis and Anti-Synthetase Syndrome. Jan. 2021. EBSCOhost, https://doi.org/10.21203/rs.2.23943/v1.

APA

llibre A, Mahoudeau A, Céline Anquetil, D. Amelin, Mathieu P Rodero, Olivier Benveniste, Karim Dorgham, Yves Allenbach, O. Landon-Cardinal, Baptiste Hervier, K. Mariampillai, S. Maillard, Toquet S, Darragh Duffy, Loïs B, Guy Gorochov, & Bondet. (2021). Ultrasensitive Interferons quantification in idiopathic inflammatory myopathies serve as biomarkers of activity in dermatomyositis and anti-synthetase syndrome. https://doi.org/10.21203/rs.2.23943/v1

Chicago

llibre A, Mahoudeau A, Céline Anquetil, D. Amelin, Mathieu P Rodero, Olivier Benveniste, Karim Dorgham, et al. 2021. “Ultrasensitive Interferons Quantification in Idiopathic Inflammatory Myopathies Serve as Biomarkers of Activity in Dermatomyositis and Anti-Synthetase Syndrome,” January. doi:10.21203/rs.2.23943/v1.